| scholarly article | Q13442814 |
| P2093 | author name string | Patricia Ferrieri | |
| Aurea E Flores | |||
| Michelle J Diedrick | |||
| Roberta Creti | |||
| Sharon L Hillier | |||
| P2860 | cites work | Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome" | Q22066389 |
| Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease | Q29028321 | ||
| Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007 | Q29301782 | ||
| Serotype IX, a Proposed New Streptococcus agalactiae Serotype | Q29305453 | ||
| Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
| Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci | Q30799389 | ||
| Gene encoding the group B streptococcal protein R4, its presence in clinical reference laboratory isolates & R4 protein pepsin sensitivity. | Q33204440 | ||
| Identification of Streptococcus agalactiae isolates from various phylogenetic lineages by matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q33436572 | ||
| Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines | Q33552269 | ||
| Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type | Q33674413 | ||
| Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens | Q33719415 | ||
| Structural and genetic diversity of group B streptococcus capsular polysaccharides | Q33768905 | ||
| DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates | Q33825669 | ||
| Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis | Q33960940 | ||
| Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates | Q33973242 | ||
| Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching | Q34041610 | ||
| Multi-locus sequence typing: a tool for global epidemiology | Q34269596 | ||
| Identification of a universal Group B streptococcus vaccine by multiple genome screen | Q34313096 | ||
| Molecular characterization of nontypeable group B streptococcus | Q34719780 | ||
| Group B streptococcal conjugate vaccines | Q35115488 | ||
| Type IV neonatal early-onset group B streptococcal disease in a United States hospital | Q35784351 | ||
| Mobile genetic elements provide evidence for a bovine origin of clonal complex 17 of Streptococcus agalactiae | Q35913325 | ||
| Neonatal & maternal group B streptococcal infections: a comprehensive review | Q35920734 | ||
| Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. | Q36098625 | ||
| Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. | Q36098790 | ||
| Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. | Q36519254 | ||
| Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. | Q36539809 | ||
| Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites | Q36898229 | ||
| Molecular analysis of multiple isolates of the major serotypes of group B streptococci | Q37137316 | ||
| Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada | Q37156816 | ||
| Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes | Q37262790 | ||
| Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine | Q37361495 | ||
| Multilocus sequence typing system for group B streptococcus | Q39757827 | ||
| Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae | Q41851462 | ||
| Improved methods for typing nontypeable isolates of group B streptococci | Q44078056 | ||
| Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups | Q46355486 | ||
| Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates | Q47252556 | ||
| Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005. | Q51103770 | ||
| Contributions of molecular epidemiology to the understanding of infectious disease transmission, pathogenesis, and evolution. | Q54450159 | ||
| Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe | Q62489009 | ||
| Molecular diversity among the trypsin resistant surface proteins of group B streptococci | Q71840680 | ||
| Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice | Q73292657 | ||
| Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program | Q74422414 | ||
| Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates | Q74753051 | ||
| Changing epidemiology of group B streptococcal colonization | Q78070314 | ||
| Distribution of PFGE types of invasive Norwegian group B streptococci in relation to serotypes | Q80277006 | ||
| Characterization of vaginal & rectal colonization with multiple serotypes of group B streptococci using multiple colony picks | Q80277012 | ||
| Streptococcus agalactiae in pregnant women: phenotypic and genotypic characters | Q80425162 | ||
| Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype | Q82703801 | ||
| Characterization of bovine and human group B streptococci isolated in Turkey | Q83059703 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 3100-3104 | |
| P577 | publication date | 2010-07-07 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States | |
| P478 | volume | 48 |
| Q64999356 | A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization. |
| Q57035529 | A Phase II Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide -Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III |
| Q37712890 | Acidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strains |
| Q39548543 | Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. |
| Q35968715 | Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains. |
| Q37040500 | Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013 |
| Q43938389 | Expression of group B protective surface protein (BPS) by invasive and colonizing isolates of group B streptococci |
| Q33587116 | Genetic diversity and antimicrobial resistance in Streptococcus agalactiae strains recovered from female carriers in the Bucharest area. |
| Q91971580 | Genomic Insights Into the Distribution and Evolution of Group B Streptococcus |
| Q90437950 | Genomic characterisation of perinatal Western Australian Streptococcus agalactiae isolates |
| Q52624533 | Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology. |
| Q33755459 | Group B streptococcusserotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution |
| Q50584451 | Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay. |
| Q83636776 | Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention |
| Q64448666 | Molecular characteristics of Streptococcus agalactiae in a mother-baby prospective cohort study: Implication for vaccine development and insights into vertical transmission |
| Q48024306 | Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching |
| Q83298166 | Multiple-locus variant-repeat assay (MLVA) is a useful tool for molecular epidemiologic analysis of Streptococcus agalactiae strains causing bovine mastitis |
| Q57169196 | Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets |
| Q35229670 | Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada |
| Q38794756 | Serotype Distribution, Population Structure, and Antimicrobial Resistance of Group B Streptococcus Strains Recovered from Colonized Pregnant Women |
| Q41629945 | Serotype IV Sequence Type 468 Group B Streptococcus Neonatal Invasive Disease, Minnesota, USA. |
| Q37093287 | Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages. |
| Q40513651 | Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010. |
| Q37535754 | Streptococcus agalactiae Serotype IV in Humans and Cattle, Northern Europe(1). |
| Q40585275 | Streptococcus agalactiae from pregnant women: antibiotic and heavy-metal resistance mechanisms and molecular typing. |
| Q61850121 | Vaginal co-colonization with multiple Group B Streptococcus serotypes |
Search more.